Lind Global Fund II LP 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-05 5:23 pm Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 10,185 9.900% |
8,979 (+744.27%) |
Filing |
| 2022-02-11 5:07 pm Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 1,206 3.300% |
1,206 (New Position) |
Filing |